Takeda, Dainippon to market schizophrenia drug

Singapore: Japanese companies Dainippon Sumitomo Pharma and Takeda Pharmaceutical have obtained approval for marketing a...

August 13, 2013 | Tuesday | News
Japan gives patent for Medgenics IFNa pump

Singapore: Medgenics received a Notice of Allowance from the Japanese Patent and Trademark Office for key claims protec...

December 7, 2012 | Friday | News
Novel oral RA treatment Xeljanz launched in Japan

Singapore: Pfizer Japan and Takeda Pharmaceutical have launched Xeljanz (tofacitinib citrate) in Japan. The medicine was...

August 6, 2013 | Tuesday | News
Japan firms keen to collaborate with Indian pharma

Singapore: Japanese companies are keen to collaborate with pharmaceutical companies in India. A delegation of pharmaceut...

February 14, 2013 | Thursday | News
Astellas to pay $300 mn for cancer drug conjugates

Singapore: Japan's Astellas Pharma has collaborated with US-based Ambrx for the discovery and development of novel antib...

April 5, 2013 | Friday | News
Eisai dissolves Palma Bee'Z Research Institute

Singapore: Japan-headquartered Eisai and its diagnostics business subsidiary Eidia have decided to dissolve and absorb t...

October 11, 2012 | Thursday | News
Shimadzu extends ultra fast mass spectrometry range

Singapore: Shimadzu UK has launched a high-end liquid chromatography mass spectrometer, the LCMS-8080, which delivers be...

August 8, 2012 | Wednesday | News
Takeda seeks bowel drug marketing nod from EU

Singapore: Takeda Pharmaceutical submitted a marketing authorization application (MAA) to the European Medicines Agency ...

March 8, 2013 | Friday | Regulatory
Japan approves Accent MRI Pacemaker

Singapore: St Jude Medical, a global medical device company, has received approval from the Japanese Ministry of Health,...

July 2, 2013 | Tuesday | Regulatory
Japan, Korea lead in stem cell race

In South Korea, two research teams led by Prof. Park Se-pill at Jeju National University Stem Cell Research Center and M...

November 12, 2012 | Monday | Opinion
Exlites eyes more medtech deals from China, Taiwan, Japan

Singapore: Exlites Holdings from the US has entered into an agreement with a company that will source new cutting edge m...

August 13, 2013 | Tuesday | News
NZ value-added dairy product launches in Japan

Singapore: New Zealand-based dairy biotechnology company, Quantec, announced that it has signed a distribution and suppl...

June 13, 2013 | Thursday | News
Otsuka schizophrenia relapse gets FDA nod

Singapore: Japan-based Otsuka Pharmaceutical and H Lundbeck have received US FDA approval for Abilify Maintena (aripipra...

March 1, 2013 | Friday | Regulatory
US FDA issues API bulk & tapped density guidance

Singapore: The US Food and Drug Administration (FDA) has issued guidance to the Active Pharmaceutical ingredient industr...

July 11, 2013 | Thursday | Regulatory
Dezima in-licenses CETP inhibitor from Mitsubishi

Singapore: Dezima Pharma, a biotechnology company developing innovative drugs in the field of dyslipidemia, has in-licen...

January 29, 2013 | Tuesday | News
South Korea approves Halaven for breast cancer

Singapore: Eisai's South Korean sales subsidiary has received approval from the regulatory authorities in South Korea to...

September 5, 2012 | Wednesday | News
Takeda's foreign recruitments suffer hostility

Singapore: The former executives and shareholders of Takeda, a leading Japanese firm, have expressed their resentment ov...

June 24, 2014 | Tuesday | News
Orexo re-submits NDA for cancer pain killer in Japan

Singapore: Swedish specialty pharmaceutical company, Orexo, revealed that that its partner Kyowa Hakko Kirin submitted ...

November 19, 2012 | Monday | News